Machina Capital S.A.S. Makes New $846,000 Investment in CVS Health Corporation $CVS

Machina Capital S.A.S. bought a new stake in shares of CVS Health Corporation (NYSE:CVS – Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 9,870 shares of the pharmacy operator’s stock, valued at approximately $846,000.

Several other institutional investors have also added to or reduced their stakes in CVS. BlackRock Inc. purchased a new stake in CVS Health during the 2nd quarter worth approximately $12,747,462,000. State Street Corp raised its holdings in shares of CVS Health by 26.3% in the second quarter. State Street Corp now owns 74,927,064 shares of the pharmacy operator’s stock worth $7,751,205,000 after buying an additional 15,604,883 shares during the last quarter. Wellington Management Group LLP lifted its stake in shares of CVS Health by 49.8% during the second quarter. Wellington Management Group LLP now owns 33,801,113 shares of the pharmacy operator’s stock worth $3,496,725,000 after buying an additional 11,233,381 shares during the period. Bank of America Corp DE lifted its stake in shares of CVS Health by 148.0% during the second quarter. Bank of America Corp DE now owns 23,188,670 shares of the pharmacy operator’s stock worth $2,398,868,000 after buying an additional 13,836,701 shares during the period. Finally, Pzena Investment Management LLC purchased a new stake in shares of CVS Health during the second quarter valued at $1,217,558,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

Trending Headlines about CVS Health

These are some of the CVS headlines that stood out recently:

  • Positive Sentiment: CVS’s recent quarterly results were strong: earnings of $2.09 per share exceeded the $1.65 consensus estimate, while revenue also topped expectations. CVS Beat Earnings by 27% and Split in Two
  • Neutral Sentiment: Wells Fargo lowered its price target to $112 from $123 but kept an Overweight rating, signaling a reduced valuation outlook while still seeing potential upside. Wells Fargo analyst rating
  • Negative Sentiment: The separation may not ease political criticism: lawmakers and critics argue that retaining CVS’s other lucrative businesses, including its pharmacy-benefit operations, would leave key drug-pricing concerns unresolved. CVS is planning a huge corporate breakup after drug price criticism

CVS Health Stock Up 0.0%

CVS opened at $89.37 on Monday. CVS Health Corporation has a fifty-two week low of $69.51 and a fifty-two week high of $110.68. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.66 and a current ratio of 0.85. The company has a fifty day moving average of $89.65 and a two-hundred day moving average of $89.09. The stock has a market capitalization of $114.34 billion, a price-to-earnings ratio of 10.40, a PEG ratio of 0.78 and a beta of 0.58.

CVS Health (NYSE:CVS – Get Free Report) last posted its quarterly earnings data on Wednesday, November 4th. The pharmacy operator reported $2.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.65 by $0.44. CVS Health had a net margin of 2.62% and a return on equity of 13.65%. The business had revenue of $108.40 billion for the quarter, compared to the consensus estimate of $104.72 billion. During the same period last year, the firm posted $1.60 earnings per share. The company’s revenue was up 5.4% compared to the same quarter last year. On average, research analysts expect that CVS Health Corporation will post 8.26 earnings per share for the current year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, November 2nd. Shareholders of record on Thursday, October 22nd were paid a dividend of $0.6650 per share. This represents a $2.66 annualized dividend and a yield of 3.0%. The ex-dividend date was Thursday, October 22nd. CVS Health’s payout ratio is 30.97%.

Analyst Upgrades and Downgrades

CVS has been the topic of a number of research reports. UBS Group cut their price objective on CVS Health from $118.00 to $107.00 and set a “buy” rating on the stock in a report on Thursday, November 5th. Cantor Fitzgerald reaffirmed a “neutral” rating on shares of CVS Health in a report on Friday, October 9th. JPMorgan Chase & Co. upped their target price on CVS Health from $111.00 to $118.00 and gave the company an “overweight” rating in a research report on Wednesday, August 12th. Leerink Partners decreased their price objective on shares of CVS Health from $112.00 to $104.00 and set an “outperform” rating for the company in a research note on Thursday, November 5th. Finally, Evercore reaffirmed an “outperform” rating on shares of CVS Health in a report on Wednesday, November 4th. Twenty-three analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $107.54.

Get Our Latest Report on CVS Health

Insider Buying and Selling

In other news, EVP Prem Shah bought 23,855 shares of the firm’s stock in a transaction dated Friday, November 6th. The shares were acquired at an average price of $83.89 per share, for a total transaction of $2,001,195.95. Following the completion of the transaction, the executive vice president directly owned 88,516 shares in the company, valued at $7,425,607.24. The trade was a 36.89% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 0.85% of the company’s stock.

CVS Health Profile

(Free Report)

CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division. The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.

Featured Articles

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS – Free Report).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.